UNLABELLED: The present study aimed to distinguish responders to cardiac resynchronization therapy (CRT) from nonresponders, using electrocardiogram-gated 18F-FDG PET/CT. METHODS: Seven consecutive CRT nonresponders were included in the study, along with 7 age- and sex-matched CRT responders, serving as reference material. Therapy response was defined as clinical improvement (≥1 New York Heart Association class) and evidence of reverse remodeling. Besides PET/CT, we measured brain natriuretic peptide levels and assessed dyssynchrony using transthoracic echocardiography. RESULTS: Compared with nonresponders, CRT responders showed significant differences in the declines of left-ventricular end-systolic volume and brain natriuretic peptide and in left-ventricular dyssynchrony (global left-ventricular entropy), extent of the myocardial scar burden, and biventricular pacemaker leads positioned within viable myocardial regions. Among the nonresponders, further therapy management was guided by the PET/CT results in 4 of 7 patients. CONCLUSION: Cardiac hybrid imaging using gated 18F-FDG PET/CT enabled the identification of potential reasons for nonresponse to CRT therapy, which can guide subsequent therapy.
UNLABELLED: The present study aimed to distinguish responders to cardiac resynchronization therapy (CRT) from nonresponders, using electrocardiogram-gated 18F-FDG PET/CT. METHODS: Seven consecutive CRT nonresponders were included in the study, along with 7 age- and sex-matched CRT responders, serving as reference material. Therapy response was defined as clinical improvement (≥1 New York Heart Association class) and evidence of reverse remodeling. Besides PET/CT, we measured brain natriuretic peptide levels and assessed dyssynchrony using transthoracic echocardiography. RESULTS: Compared with nonresponders, CRT responders showed significant differences in the declines of left-ventricular end-systolic volume and brain natriuretic peptide and in left-ventricular dyssynchrony (global left-ventricular entropy), extent of the myocardial scar burden, and biventricular pacemaker leads positioned within viable myocardial regions. Among the nonresponders, further therapy management was guided by the PET/CT results in 4 of 7 patients. CONCLUSION: Cardiac hybrid imaging using gated 18F-FDG PET/CT enabled the identification of potential reasons for nonresponse to CRT therapy, which can guide subsequent therapy.
Authors: Sebastian Lehner; Christopher Uebleis; Franziska Schüßler; Alexander Haug; Stefan Kääb; Peter Bartenstein; Serge D Van Kriekinge; Guido Germano; Heidi Estner; Marcus Hacker Journal: Eur J Nucl Med Mol Imaging Date: 2013-08-01 Impact factor: 9.236
Authors: Christopher Uebleis; Xaver Hoyer; Serge D Van Kriekinge; Franziska Schuessler; Rüdiger Paul Laubender; Alexander Becker; Sebastian Lehner; Andrei Todica; Alexander Haug; Peter Bartenstein; Paul Cumming; Guido Germano; Marcus Hacker Journal: J Nucl Cardiol Date: 2013-01-25 Impact factor: 5.952
Authors: Wael AlJaroudi; M Chadi Alraies; Rory Hachamovitch; Wael A Jaber; Richard Brunken; Manuel D Cerqueira; Thomas Marwick Journal: Eur J Nucl Med Mol Imaging Date: 2012-06-15 Impact factor: 9.236
Authors: Luis Eduardo Juárez-Orozco; Erick Alexanderson; Rudi A Dierckx; Hendrikus H Boersma; Johannes L Hillege; Clark J Zeebregts; Myriam M Martínez-Aguilar; Antonio Jordán-Ríos; Ana Gabriela Ayala-German; Niek Prakken; Rene A Tio; Riemer H Slart Journal: J Nucl Cardiol Date: 2016-09-28 Impact factor: 5.952
Authors: Luis Eduardo Juarez-Orozco; Andrea Monroy-Gonzalez; Niek H J Prakken; Walter Noordzij; Juhani Knuuti; Robert A deKemp; Riemer H J A Slart Journal: J Nucl Cardiol Date: 2019-03-04 Impact factor: 5.952